Geriatricians' role in the management of aortic stenosis in frail older patients: a decade later.
Aortic valve replacement
Comprehensive geriatric assessment
Frailty
Heart team
Transcatheter aortic valve implantation
Journal
European geriatric medicine
ISSN: 1878-7649
Titre abrégé: Eur Geriatr Med
Pays: Switzerland
ID NLM: 101533694
Informations de publication
Date de publication:
22 Jul 2024
22 Jul 2024
Historique:
received:
04
02
2024
accepted:
25
06
2024
medline:
22
7
2024
pubmed:
22
7
2024
entrez:
22
7
2024
Statut:
aheadofprint
Résumé
Increasing evidence supports the implementation of geriatric assessment in the workup of older patients with aortic stenosis (AS). In 2012, an online European survey revealed that geriatricians were rarely involved in the assessment of candidates for transcatheter aortic valve implantation (TAVI). After a "call to action" for early involvement of geriatricians in AS evaluation, the survey was repeated in 2022. Our aim was to investigate whether geriatricians' role changed in the last decade. Online survey conducted between December 16th, 2021, and December 15th, 2022. All members of the European Geriatric Medicine Society were invited to participate. The survey included 26 questions regarding geriatricians' experience with AS and TAVI. Among 193 respondents (79.8% geriatricians), 73 (38%) reported to be involved in AS evaluation at least once a week. During 2 years prior to the survey, 43 (22.3%) had referred > 50% of their patients with severe AS for TAVI. Age influenced TAVI referral in a considerable proportion of respondents (36.8%). TAVI candidates were mainly referred to specialised cardiac centres with multidisciplinary teams (91.8%), including (47.2%) or not including (44.6%) a geriatrician. A total of 38.9% of respondents reported to be part of a multidisciplinary heart team. Geriatricians were less frequently involved (37%) than cardiologists (89.6%) and surgeons (53.4%) in pre-procedural TAVI management. Cardiologists were more frequently involved (85.5%) than geriatricians (33.7%) and surgeons (26.9%) in post-procedural management. Geriatricians' involvement in AS management and multidisciplinary heart teams remains scarce. More efforts should be devoted to implement geriatricians' role in AS decision-making.
Identifiants
pubmed: 39037643
doi: 10.1007/s41999-024-01015-9
pii: 10.1007/s41999-024-01015-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Osnabrugge RLJ, Mylotte D, Head SJ et al (2013) Aortic stenosis in the elderly. J Am Coll Cardiol 62:1002–1012. https://doi.org/10.1016/j.jacc.2013.05.015
doi: 10.1016/j.jacc.2013.05.015
pubmed: 23727214
Pulignano G, Gulizia MM, Baldasseroni S et al (2017) ANMCO/SIC/SICI-GISE/SICCH executive summary of consensus document on risk stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement. Euro Heart J Suppl 19:D354–D369. https://doi.org/10.1093/eurheartj/sux012
doi: 10.1093/eurheartj/sux012
Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198. https://doi.org/10.1056/NEJMoa1103510
doi: 10.1056/NEJMoa1103510
pubmed: 21639811
Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620. https://doi.org/10.1056/NEJMoa1514616
doi: 10.1056/NEJMoa1514616
pubmed: 27040324
Mack MJ, Leon MB, Thourani VH et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695–1705. https://doi.org/10.1056/NEJMoa1814052
doi: 10.1056/NEJMoa1814052
pubmed: 30883058
Vahanian A, Beyersdorf F, Praz F et al (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43:561–632. https://doi.org/10.1093/eurheartj/ehab395
doi: 10.1093/eurheartj/ehab395
pubmed: 34453165
Goudzwaard JA, de Ronde-Tillmans MJAG, van Hoorn FED et al (2020) Impact of frailty on health-related quality of life 1 year after transcatheter aortic valve implantation. Age Ageing 49:989–994. https://doi.org/10.1093/ageing/afaa071
doi: 10.1093/ageing/afaa071
pubmed: 32421189
pmcid: 7583518
Arnold SV, Cohen DJ, Dai D et al (2018) Predicting Quality of life at 1 year after transcatheter aortic valve replacement in a real-world population. Circ Cardiovasc Qual Outcomes. https://doi.org/10.1161/CIRCOUTCOMES.118.004693
doi: 10.1161/CIRCOUTCOMES.118.004693
pubmed: 30354578
pmcid: 6214661
Kennon S, Styra R, Bonaros N et al (2021) Quality of life after transcatheter or surgical aortic valve replacement using the Toronto aortic stenosis quality of life questionnaire. Open Heart 8:1–8. https://doi.org/10.1136/openhrt-2021-001821
doi: 10.1136/openhrt-2021-001821
Schoenenberger AW, Stortecky S, Neumann S et al (2013) Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J 34:684–692. https://doi.org/10.1093/eurheartj/ehs304
doi: 10.1093/eurheartj/ehs304
pubmed: 23008508
Biancari F, Rosato S, Costa G et al (2021) A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement. Eur J Cardiothorac Surg 59:586–592. https://doi.org/10.1093/ejcts/ezaa375
doi: 10.1093/ejcts/ezaa375
pubmed: 33575794
Bertschi D, Moser A, Stortecky S et al (2021) Evolution of basic activities of daily living function in older patients one year after transcatheter aortic valve implantation. J Am Geriatr Soc 69:500–505. https://doi.org/10.1111/jgs.16927
doi: 10.1111/jgs.16927
pubmed: 33156520
Solla-Suárez P, Avanzas P, Fernández-Fernández M et al (2023) Functional continuum: independent predictor of one-year mortality and key decision-making element in older adults with severe aortic stenosis amenable to aortic valve replacement. Aging Clin Exp Res 35:323–331. https://doi.org/10.1007/s40520-022-02300-y
doi: 10.1007/s40520-022-02300-y
pubmed: 36417136
Green P, Woglom AE, Genereux P et al (2012) Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis. Clin Cardiol 35:307–314. https://doi.org/10.1002/clc.21974
doi: 10.1002/clc.21974
pubmed: 22331630
pmcid: 3702449
Afilalo J, Lauck S, Kim DH et al (2017) Frailty in older adults undergoing aortic valve replacement. J Am Coll Cardiol 70:689–700. https://doi.org/10.1016/j.jacc.2017.06.024
doi: 10.1016/j.jacc.2017.06.024
pubmed: 28693934
Ungar A, Mannarino G, van der Velde N et al (2018) Comprehensive geriatric assessment in patients undergoing transcatheter aortic valve implantation - results from the CGA-TAVI multicentre registry. BMC Cardiovasc Disord 18:1. https://doi.org/10.1186/s12872-017-0740-x
doi: 10.1186/s12872-017-0740-x
pubmed: 29301486
pmcid: 5755352
Boureau AS, Trochu JN, Colliard C et al (2015) Determinants in treatment decision-making in older patients with symptomatic severe aortic stenosis. Maturitas 82:128–133. https://doi.org/10.1016/j.maturitas.2015.06.033
doi: 10.1016/j.maturitas.2015.06.033
pubmed: 26142654
Niebauer J, Bäck C, Bischoff-Ferrari HA et al (2023) Preinterventional frailty assessment in patients scheduled for cardiac surgery or transcatheter aortic valve implantation: a consensus statement of the European association for cardio-thoracic surgery (EACTS) and the European association of preventive cardiology (EAPC) of the European society of cardiology (ESC). Eur J Prev Cardiol. https://doi.org/10.1093/eurjpc/zwad304
doi: 10.1093/eurjpc/zwad304
pubmed: 37458001
Afilalo J (2011) Frailty in patients with cardiovascular disease: why, when, and how to measure. Curr Cardiovasc Risk Rep 5:467–472. https://doi.org/10.1007/s12170-011-0186-0
doi: 10.1007/s12170-011-0186-0
pubmed: 21949560
pmcid: 3165117
Rowe R, Iqbal J, Murali-Krishnan R et al (2014) Role of frailty assessment in patients undergoing cardiac interventions. Open Heart. https://doi.org/10.1136/openhrt-2013-000033
doi: 10.1136/openhrt-2013-000033
pubmed: 25332792
pmcid: 4195918
Sze S, Pellicori P, Zhang J et al (2019) Identification of frailty in chronic heart failure. JACC Heart Fail 7:291–302. https://doi.org/10.1016/j.jchf.2018.11.017
doi: 10.1016/j.jchf.2018.11.017
pubmed: 30738977
Ungar A, Rivasi G, Petrovic M et al (2020) Toward a geriatric approach to patients with advanced age and cardiovascular diseases: position statement of the EuGMS special interest group on cardiovascular medicine. Eur Geriatr Med 11:179–184. https://doi.org/10.1007/s41999-019-00267-0
doi: 10.1007/s41999-019-00267-0
pubmed: 32297238
Ungar A, Bramlage P, Thoenes M et al (2013) A call to action - Geriatricians’ experience in treatment of aortic stenosis and involvement in transcatheter aortic valve implantation. Eur Geriatr Med 4:176–182. https://doi.org/10.1016/j.eurger.2013.04.007
doi: 10.1016/j.eurger.2013.04.007
Ismayl M, Abbasi MA, Al-Abcha A et al (2023) Outcomes of transcatheter aortic valve implantation in nonagenarians and octogenarians (analysis from the national inpatient sample database). Am J Cardiol 199:59–70. https://doi.org/10.1016/j.amjcard.2023.04.049
doi: 10.1016/j.amjcard.2023.04.049
pubmed: 37257370
Brouessard C, Bobet AS, Mathieu M et al (2021) Impact of severe sarcopenia on rehospitalization and survival one year after a TAVR procedure in patients aged 75 and older. Clin Interv Aging 16:1285–1292. https://doi.org/10.2147/CIA.S305635
doi: 10.2147/CIA.S305635
pubmed: 34262268
pmcid: 8274520
Ijaz N, Buta B, Xue Q-L et al (2022) Interventions for frailty among older adults with cardiovascular disease. J Am Coll Cardiol 79:482–503. https://doi.org/10.1016/j.jacc.2021.11.029
doi: 10.1016/j.jacc.2021.11.029
pubmed: 35115105
pmcid: 8852369
Rudolph T, Appleby C, Delgado V et al (2023) Patterns of aortic valve replacement in Europe: adoption by age. Cardiology 148:547–555. https://doi.org/10.1159/000533633
doi: 10.1159/000533633
pubmed: 37586346
Iung B, Delgado V, Rosenhek R et al (2019) Contemporary presentation and management of valvular heart disease. Circulation 140:1156–1169. https://doi.org/10.1161/CIRCULATIONAHA.119.041080
doi: 10.1161/CIRCULATIONAHA.119.041080
pubmed: 31510787
Demir OM, Curio J, Pagnesi M et al (2022) Transcatheter aortic valve replacement in nonagenarians: a systematic review and meta-analysis. J Invasive Cardiol 34:E226–E236
doi: 10.25270/jic/21.00165
pubmed: 35235529
Noguchi M, Tabata M, Obunai K et al (2021) Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention - TAVI registry. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.28935
doi: 10.1002/ccd.28935
pubmed: 34357673
pmcid: 9292175
Archbold A, Akowuah E, Banning AP et al (2022) Getting the best from the heart team: guidance for cardiac multidisciplinary meetings. Heart 108:e2–e2. https://doi.org/10.1136/heartjnl-2021-320510
doi: 10.1136/heartjnl-2021-320510
pubmed: 35396217
Rosseel L, Mylotte D, Cosyns B et al (2023) Contemporary European practice in transcatheter aortic valve implantation: results from the 2022 European TAVI pathway registry. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2023.1227217
doi: 10.3389/fcvm.2023.1227217
pubmed: 37645516
pmcid: 10389707
Fountotos R, Lauck S, Piazza N et al (2023) Protein and exercise to reverse frailty in older men and women undergoing transcatheter aortic valve replacement: design of the PERFORM-TAVR trial. Can J Cardiol. https://doi.org/10.1016/j.cjca.2023.11.037
doi: 10.1016/j.cjca.2023.11.037
pubmed: 38052302
Jepma P, Verweij L, Buurman BM et al (2021) The nurse-coordinated cardiac care bridge transitional care programme: a randomised clinical trial. Age Ageing 50:2105–2115. https://doi.org/10.1093/ageing/afab146
doi: 10.1093/ageing/afab146
pubmed: 34304264
pmcid: 8581392
Van Grootven B, Jeuris A, Jonckers M et al (2021) Geriatric co-management for cardiology patients in the hospital: a quasi-experimental study. J Am Geriatr Soc 69:1377–1387. https://doi.org/10.1111/jgs.17093
doi: 10.1111/jgs.17093
pubmed: 33730373
Damluji AA, Bernacki G, Afilalo J et al (2024) TAVR in older adults. JACC Adv 3:100877. https://doi.org/10.1016/j.jacadv.2024.100877
doi: 10.1016/j.jacadv.2024.100877
pubmed: 38694996
pmcid: 11062620